FDA Clears Ikaria Inc.'s INOMAX® DSIR to Connect With Hospital Health Information Systems
11/13/2012 9:48:58 AM
More...
|
Ikaria Inc. to Present at 2012 Biotechnology Industry Organization (BIO) International Convention
6/13/2012 10:06:15 AM
More...
|
Ikaria Inc.'s LUCASSIN® Approved in Australia
4/24/2012 6:54:39 AM
More...
|
Ikaria Inc. Appoints Chief Medical Officer
4/11/2012 10:10:34 AM
More...
|
FDA Clears Expanded Compatibility for Ikaria Inc.'s INOMAX® Drug-Delivery Systems
3/21/2012 8:27:00 AM
More...
|
Ikaria Inc. Completes Patient Enrollment in Pivotal Phase III Trial for Bronchopulmonary Dysplasia
2/27/2012 6:43:19 AM
More...
|
Ikaria Inc. to Present at 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/7/2012 8:50:26 AM
More...
|
FDA Grants Orphan Drug Designation to Ikaria Inc. For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension
1/24/2012 9:22:43 AM
More...
|
Ikaria Inc. Recalls Drug Delivery System
1/9/2012 8:40:24 AM
More...
|
Ikaria Inc. to Present at Biotech Showcase(TM) 2012
1/4/2012 1:28:06 PM
More...
|
|